NeuroPace (NPCE) Free Cash Flow (2020 - 2026)
NeuroPace's (NPCE) quarterly Free Cash Flow came in at -$6.0 million in Q1 2026, up 20.17% year-on-year from -$5.0 million in Q1 2025, and down 1593.05% quarter-over-quarter from $403000.0 in Q4 2025.
NeuroPace (NPCE) Free Cash Flow (2020 - 2026) Analysis & Trends
NeuroPace's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$6.0 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 20.17% year-over-year to -$6.0 million in Q1 2026; TTM through Mar 2026 was -$9.8 million, a 45.19% increase from a year earlier, with the FY2025 full-year figure at -$11.3 million, up 36.76% from the prior year.
- Free Cash Flow fell to -$6.0 million in Q1 2026 per NPCE's latest filing, from $403000.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $403000.0 in Q4 2025 and bottomed at -$11.4 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$4.5 million (2024), against an average of -$5.4 million.
- Across the five-year window, Free Cash Flow slumped 93.75% in 2022 and soared 109.05% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$8.0 million in 2022, then surged by 58.22% to -$3.3 million in 2023, then sank by 33.61% to -$4.5 million in 2024, then jumped by 109.05% to $403000.0 in 2025, then plunged by 1593.05% to -$6.0 million in 2026.
- Per Business Quant, the three latest NPCE Free Cash Flow figures stand at -$6.0 million (Q1 2026), $403000.0 (Q4 2025), and -$2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.02 Mn |
| Mar 31, 2026 | -6.02 Mn |
| Dec 31, 2025 | 403,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Sep 30, 2025 | -1.96 Mn |
| Sep 30, 2025 | -1.96 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | -7.54 Mn |
| Mar 31, 2025 | -7.54 Mn |
| Dec 31, 2024 | -4.45 Mn |
| Dec 31, 2024 | -4.45 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Jun 30, 2024 | -4.04 Mn |
| Jun 30, 2024 | -4.04 Mn |
| Mar 31, 2024 | -7.56 Mn |
| Mar 31, 2024 | -7.56 Mn |
| Dec 31, 2023 | -3.33 Mn |
| Dec 31, 2023 | -3.33 Mn |